Sanara MedTech Inc. Common Stock
$35.07
$0.09 (+0.26%)
$34.94Day Range$35.13
Key Statistics
Market Cap
$322.22M
Shares Outstanding
9.2M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 2, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$34.98
Day High
$35.13
Day Low
$34.94
Volume
271.1K
VWAP
$35.07
Prev Close
$34.98
Transactions
--
Acc. Volume
--
About Sanara MedTech Inc. Common Stock
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIESSIC 3842108 employees1200 SUMMIT AVE, FORT WORTH, TX, 76102817-529-2300IPO Nov 2, 2020US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000714256
- Composite FIGI
- BBG000KLGDZ6
- Share Class FIGI
- BBG001SKS528
- Ticker Root
- SMTI
- SIC Code
- 3842
About Sanara MedTech Inc. Common Stock (SMTI) Stock
Sanara MedTech Inc. Common Stock (SMTI) closed the 2026-09-18 session at $35.07, up 0.26% versus the previous close (+0.09). The stock opened at $34.98 and traded between $34.94 and $35.13 during that session. Session trading volume was 271K shares. The volume-weighted average price (VWAP) is $35.07.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Sanara MedTech Inc. Common Stock has a market capitalization of $322.2 million. The company operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES industry classification. SMTI is listed on the XNAS exchange. The company employs approximately 108 people. Sanara MedTech Inc. Common Stock is headquartered in FORT WORTH, TX. The recorded listing date is 2020-11-02.
On this page you can find market SMTI stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector.